Search

By Industry Solutions (2)
By Phase (1)
By Molecule Type (1)
By Therapeutic Area (3)
Covance Events (9)
Geography (3)
Keywords (10)

Filters

Showing results 801 - 816 of 91813 for .

Showing results 801 - 816 of 91813 for .

Keen Insight Improves Cause of Study Direction: Phase I Oncology Case Study
Past experience was leveraged to improve the course of several Phase I oncology dose-escalation studies.
Precision Delivery. Inspiring Results: Cardiovascular Outcomes Case Study
Precision Delivery. Inspiring Results: Cardiovascular Outcomes Case Study
Rapid Start-Up for a Pivotal Trial in Non-Alcoholic Steatohepatitis (NASH): A Case Study
Solutions for global site activation and clinical trial monitoring to overcome enrollment challenges, retain long-term patients and reach First Patient In (FPI) milestone as quickly as possible.
Transforming Risks into Returns: Risk-Based Monitoring Case Study (Adaptive Monitoring)
Transforming Risks into Returns: Risk-Based Monitoring Case Study (Adaptive Monitoring)
Transforming Risks into Returns: Risk-Based Monitoring Case Study (Endpoint Study)
Transforming Risks into Returns: Risk-Based Monitoring Case Study (Endpoint Study)
Transforming Risks Into Returns: Risk-Based Monitoring Case Study
Transforming Risks Into Returns: Risk-Based Monitoring Case Study
Incorporating Patient Insights into a Rare Disease Clinical Protocol
Engaging with patients and designing a patient-centric protocol in any rare disease clinical trial is a major challenge. To learn more about Fabry patients' experience with the disease and their potential concerns with joining a study, Covance designed a new strategy combining patient data from a globally-deployed survey, as well as leveraging proprietary clinical data.
Informed Market Access Strategy: A Case Study on European Reimbursement and Market Access Assessment for Medical Devices
Learn how research led to the decision that an immediate launch in the out-of-pocket/private market would be the most successful market access strategy.
Revealing Opportunities Through Insightful Informatics: Cardiovascular Outcomes Case Study
Revealing Opportunities Through Insightful Informatics: Cardiovascular Outcomes Case Study
Review. Revise. Results. Global Regulatory Affairs Case Study
Review. Revise. Results. Global Regulatory Affairs Case Study
Gain Confidence in Bringing New Products to Market with Shelf-Life Studies
When introducing a new product, food manufacturers need to ensure that their product doesn't put the safety of their customers or their brands at risk.
Maximizing the Potential of South Africa: Emerging Markets Case Study
A global Phase III cardiovascular study included 20 sites in South Africa with a target enrolllment of more than 410 patients.
Preserving Billions in Potential Revenue: Actionable Insights from GlobalCODE® Analytics Rescue a Phase III Adaptive Oncology Trial
In a late stage oncology trial for a drug intended to be marketed in Asia, the Data Safety and Monitoring Board (DSMB) noted an apparent decrease in some patients' white blood cell counts in the new drug treatment arm. The client sought to understand whether the drug was responsible for this effect and, if so, what actions could be taken to improve the drug's safety. Using GlobalCODE®, the client prompted a change to the trial testing schedule and was ultimately able to proceed to a new...
Codified, Readily Available Informed Consent Gives One Pharmaceutical Company an Estimated $1b First-To-Market Advantage
One year into pivotal trials in the development of a Hepatitis C virus (HCV) drug and, a large pharmaceutical company had a competitor which was three months ahead in their development. Research that came to the attention of the U.S. Food and Drug Administration (FDA) revealed an increased response to HCV treatment by patients possessing a specific IL28b genotype. The robust informatics and proactive management of consent gave the company the ability to leap-frog the competition and gain...
Superb Time-Management + Continuous Communication = Efficient Study Conduct: Emerging Pharma
Conducting an open-label extension study for a small emerging biotech company's molecule in order to gain confidence in its safety profile before filing for approval in the US.